IP Library Granted Patent US 7,241,860
Granted Patent B1
US 7,241,860 · App. 10/130,872 · Granted Jul 10, 2007

Transcription factor polypeptide that regulates Chondromodulin-I expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,241,860
App. No.
10/130,872
Granted
Jul 10, 2007
Kind
B1
Abstract

The polypeptide of the present invention has an activity of binding specifically to the cis-element of Chondromodulin-I (ChM-I) gene promoter and promoting the transcription of the ChM-I gene. The polypeptide of the present invention is usable in screening for a compound that promotes or inhibits the activity of the polypeptide.

Claims (7)

1. An isolated polypeptide or salt thereof, which polypeptide consists of the amino acid sequence of SEQ ID NO: 5.

2. An isolated polypeptide or salt thereof, which polypeptide consists of the amino acid sequence of SEQ ID NO: 4.

3. An isolated polypeptide or salt thereof, which polypeptide consists of the amino acid sequence of SEQ ID NO: 19.

4. An isolated polypeptide or salt thereof, which polypeptide consists of the amino acid sequence of SEQ ID NO: 7.

5. A kit for screening a compound or a salt thereof that promotes or inhibits the activity of the polypeptide or salt thereof according to any one of claims 1 to 4 , comprising the polypeptide or salt thereof according to any one of claims 1 to 4 .

6. A method of manufacturing the polypeptide or a salt thereof according to any one of claims 1 to 4 , which comprises culturing a transformant transformed with a recombinant vector comprising a DNA comprising a base sequence encoding the polypeptide according to any one of claims 1 to 4 to produce the polypeptide or salt thereof according to any one of claims 1 to 4 .

7. A method of screening a compound or a salt thereof that promotes or inhibits the activity of the polypeptide or salt thereof according to any one of claims 1 to 4 , which comprises the steps of (i) contacting a DNA comprising a chondromodulin-I promoter with the polypeptide of any one of claims 1 to 4 in the presence and absence of a test compound, and (ii) comparing the amounts of the polypeptide bound to the chondromodulin-I promoter in the presence and absence of the test compound, thereby identifying the compound or salt thereof that promotes or inhibits the activity of the polypeptide or salt thereof of any one of claims 1 to 4 to the chondromodulin-I promoter.

Assignments (3)
CHANGE OF NAME Recorded May 29, 2007
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 019355/0193 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2007
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 019013/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2002
From: YOSHIMURA, KOJI; HIKICHI, YUICHI; NOGUCHI, KENICHI
To: TAKEDA CHEMICAL INDUSTRIES, LTD.
Reel/Frame 013164/0750 →